Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Merck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics 2020-11-09 21:00
Pierre Fabre initiates a "First in Human" clinical trial for an innovative monoclonal antibody (W0180) targeting the VISTA checkpoint in patients with solid tumors 2020-11-09 20:57
Covid-19 Vaccination Plan: Badan POM Set to Ensure and Safeguard the safety, efficacy, and quality of Covid-19 vaccine 2020-11-09 17:25
Merck and Transcenta Collaborate to Advance Continuous Biomanufacturing, Make the 'Facility of the Future' a Reality 2020-11-08 17:14
Merck to Collaborate with Donghao Lansheng to Pilot New Import Policy in China 2020-11-08 17:08
XJTLU launches new Academy of Pharmacy 2020-11-06 20:00
Semaglutide 2.4 mg injection demonstrated significant weight loss versus placebo when added to intensive behavioural therapy 2020-11-06 01:50
TCM Lianhua Qingwen's Access to Russian Market Marks Its Global Expansion 2020-11-05 14:08
Innovent and Lilly Jointly Announce Results of Seven Clinical Studies of TYVYT® (sintilimab injection) to Be Presented at the ESMO ASIA Congress 2020 2020-11-05 08:00
U.S. FDA Accepts Ortho's Emergency Use Notification for VITROS(R) SARS-CoV-2 Antigen Test--Capable of Accurate Mass-Scale Testing 2020-11-05 07:23
Jubilant Radiopharma and SOFIE Biosciences Ink Strategic Partnership Deal to Further Advance the Field of Molecular Imaging & Therapeutics 2020-11-04 21:00
Leading Cell Therapy Company JW Therapeutics Lists on Main Board of HKEX 2020-11-03 10:37
SK Biopharmaceuticals and LifeSci Venture Partners Forge Ties for Open Innovation 2020-11-03 00:46
RevImmune advances new immunotherapy in COVID-19 2020-11-02 21:00
Clarivate Expands International Real-World Data Offering with Addition of Techtrials Brazilian Dataset 2020-11-02 21:00
GP(HK) Enters into A Few Agreements in the Field of Cancer Diagnostics and Treatment 2020-11-02 17:01
Ocumension Therapeutics Strengthens Pipeline for Posterior Segment Eye Diseases 2020-10-30 10:54
AGC Biologics and Horizon Therapeutics plc Expand Partnership 2020-10-30 03:17
Complete Data from Connect Biopharma's Phase 1b Study of CBP-201 Demonstrate Rapid, Early and Continuous Improvement in Patient Quality of Life and Atopic Dermatitis (AD) Symptoms 2020-10-29 19:00
Asieris' APL-1501 Approved for Phase I Clinical Trial in Australia 2020-10-29 09:35
1 145 146 147 148 149 234